Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment: A Pilot Study.
Document Type
Article
Publication Date
8-31-2020
Publication Title
Metabolites
Abstract
The lack of sensitive and specific biomarkers for the early detection of mild cognitive impairment (MCI) and Alzheimer's disease (AD) is a major hurdle to improving patient management. A targeted, quantitative metabolomics approach using both
Volume
10
Issue
9
Recommended Citation
Yilmaz A, Ugur Z, Bisgin H, Akyol S, Bahado-Singh R, Wilson G, Imam K, Maddens ME, Graham SF. Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment: A Pilot Study. Metabolites. 2020 Aug 31;10(9):357. doi: 10.3390/metabo10090357. PMID: 32878308; PMCID: PMC7569858.
DOI
10.3390/metabo10090357
ISSN
2218-1989
PubMed ID
32878308
COinS